GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 205 filers reported holding GENMAB A/S in Q3 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $20,420,930 | -35.9% | 481,853 | -51.4% | 0.04% | -35.7% |
| Q3 2022 | $31,849,000 | -30.9% | 991,261 | -30.1% | 0.06% | -28.2% |
| Q2 2022 | $46,088,000 | -47.0% | 1,418,534 | -40.9% | 0.08% | -32.2% |
| Q1 2022 | $86,878,000 | -17.0% | 2,401,280 | -9.2% | 0.12% | -7.3% |
| Q4 2021 | $104,665,000 | -13.6% | 2,645,741 | -4.6% | 0.12% | -16.2% |
| Q3 2021 | $121,151,000 | -9.0% | 2,772,328 | -15.0% | 0.15% | -6.9% |
| Q2 2021 | $133,142,000 | +22.4% | 3,260,882 | -1.6% | 0.16% | +15.2% |
| Q1 2021 | $108,805,000 | -32.0% | 3,314,182 | -15.8% | 0.14% | -29.2% |
| Q4 2020 | $160,114,000 | +2.8% | 3,937,874 | -7.5% | 0.20% | -11.4% |
| Q3 2020 | $155,812,000 | +6.1% | 4,256,006 | -1.8% | 0.22% | -6.4% |
| Q2 2020 | $146,879,000 | +94.2% | 4,333,980 | +21.4% | 0.24% | +45.1% |
| Q1 2020 | $75,636,000 | -9.3% | 3,569,409 | -4.4% | 0.16% | +11.0% |
| Q4 2019 | $83,383,000 | +7.0% | 3,734,123 | -2.9% | 0.15% | -0.7% |
| Q3 2019 | $77,922,000 | – | 3,846,111 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 242,848 | $9,169,940 | 3.80% |
| Capricorn Fund Managers Ltd | 110,643 | $4,177,880 | 1.28% |
| Arlington Capital Management, Inc. | 35,591 | $1,343,916 | 1.26% |
| XY Capital Ltd | 76,884 | $2,903,140 | 1.13% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 88,000 | $3,322,880 | 0.93% |
| TORRAY INVESTMENT PARTNERS LLC | 110,807 | $4,184,072 | 0.75% |
| Hardman Johnston Global Advisors LLC | 585,139 | $22,094,849 | 0.72% |
| Yorktown Management & Research Co Inc | 16,600 | $626,816 | 0.68% |
| First Light Asset Management, LLC | 160,025 | $6,042,544 | 0.54% |
| MIRABELLA FINANCIAL SERVICES LLP | 28,260 | $2,505,855 | 0.38% |